Pacira Pharmaceuticals buy StockNews.com
Start price
08.11.25
/
50%
€19.20
Target price
08.11.26
-
Performance (%)
2.60%
Price
16.04.26
€19.70
Summary
This prediction is currently active. With a performance of 2.60%, the BUY prediction by StockNews_com for Pacira Pharmaceuticals is trending in the right direction. This prediction currently runs until 08.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacira Pharmaceuticals | -2.475% | -2.475% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by StockNews_com for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences (NASDAQ:PCRX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by StockNews_com for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€35.80
05.08.23
05.08.23
-
05.08.24
05.08.24
-46.93%
06.08.24
06.08.24
